Cold Plasma Cancer Therapy

PRELIMS.pdf
	Acknowledgements
	Author biographies
		Michael Keidar
		Dayun Yan
		Jonathan H Sherman
CH001.pdf
	Chapter 1 Plasma as a fourth state of matter
		1.1 Plasma types
		References
CH002.pdf
	Chapter 2 Introduction to the non-thermal plasmas
		References
CH003.pdf
	Chapter 3 The anti-cancer effect of cold atmospheric plasma in vitro
		3.1 The research status
		3.2 The specific vulnerability of cancer cells to cap
		3.3 The long-term cellular responses
		3.4 The selective anti-cancer effect
		3.5 The short-term cellular respones
		References
CH004.pdf
	Chapter 4 The anti-cancer mechanism of cold atmospheric plasma in vitro
		4.1 The activation of cancer cells
		4.2 The reactive species
		4.3 The rise of intracellular ROS
		4.4 The selective anti-cancer mechanism
		References
CH005.pdf
	Chapter 5 The anti-cancer effect of CAP treatment in vivo
		5.1 Introduction
		5.2 The in vivo demonstration
		5.3 The clinical demonstration
		5.4 Mechanism
		5.5 Reactive species and skin
		References
CH006.pdf
	Chapter 6 Indirect CAP treamtent, the application of the cold atmospheric plasma-activated solutions in cancer treatment
		6.1 Introduction
		6.2 The CAP-activated medium
		6.3 The reactive species in PAS
		6.4 The principles to make PAS
		References
CH007.pdf
	Chapter 7 Adaptive plasmas and recent progress in plasma application in cancer therapy
		7.1 Plasma self-organization phenomena
		7.2 Adaptive plasma devices
		7.3 MPC-based adaptive plasma platform
		References
CH008.pdf
	Chapter 8 Clinical applications of cold atmospheric plasma for glioblastoma
		8.1 Introduction
		8.2 Cold atmospheric plasma as a potential mediator of immune stimulation
			Glioblastoma-mediated suppression of the systemic and local immune system
			Current immunotherapy approaches in the treatment of GBM
			Cold-activated plasma’s role in immunotherapy
		8.3 Cold atmospheric plasma-mediated inflammation as a promoter of mesenchymal stem cell localization
			Mesenchymal stem cells and the tumor microenvironment
			Cold atmospheric plasma inflammation as a mediator of mesenchymal stem cell recruitment
			Cold atmospheric plasma and miR-MSC adjuvant therapy in the treatment of glioblastoma
		8.4 Cold atmospheric plasma and nanoparticles applied as a synergistic cancer therapy
			Nanoparticles and the tumor microenvironment
			Cold atmospheric plasma with platinum nanoparticle adjunct therapy
			Cold atmospheric plasma with gold nanoparticle adjunct therapy
			The future of cold atmospheric plasma and nanoparticle adjunct therapy
		8.5 Facing forward: cold atmospheric plasma treatment of glioblastoma
		Acknowledgements
		References